Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

Clinical trial NCT01605032 · COMPLETED

Trial details

NCT number: NCT01605032
Sponsor: Albert Einstein College of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

DS Stage I Plasma Cell Myeloma DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2012-02-01
Primary completion: 2018-03-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.